Short Interest in Aterian, Inc. (NASDAQ:ATER) Decreases By 76.0%

Aterian, Inc. (NASDAQ:ATER) was the recipient of a significant drop in short interest in the month of May. As of May 15th, there was short interest totaling 465,657 shares, a drop of 76.0% from the April 30th total of 1,939,342 shares. Based on an average daily trading volume, of 923,391 shares, the short-interest ratio is presently 0.5 days. Approximately 5.3% of the company’s shares are short sold.

Institutional Trading of Aterian

Hedge funds have recently modified their holdings of the business. Goldman Sachs Group Inc. grew its holdings in shares of Aterian by 73.0% during the 1st quarter. Goldman Sachs Group Inc. now owns 21,392 shares of the company’s stock valued at $45,000 after acquiring an additional 9,026 shares in the last quarter. XTX Topco Ltd bought a new position in shares of Aterian during the 2nd quarter valued at $55,000. Citadel Advisors LLC raised its holdings in shares of Aterian by 222.0% during the 3rd quarter. Citadel Advisors LLC now owns 33,165 shares of the company’s stock valued at $35,000 after purchasing an additional 22,865 shares in the last quarter. Finally, Susquehanna International Group LLP raised its holdings in shares of Aterian by 310.2% during the 3rd quarter. Susquehanna International Group LLP now owns 40,512 shares of the company’s stock valued at $43,000 after purchasing an additional 30,637 shares in the last quarter. Hedge funds and other institutional investors own 7.02% of the company’s stock.

Aterian Stock Performance

Shares of ATER traded down $0.04 during mid-day trading on Friday, reaching $1.12. 65,458 shares of the company’s stock traded hands, compared to its average volume of 2,811,804. The business’s 50-day moving average price is $0.86 and its 200-day moving average price is $0.76. The stock has a market capitalization of $12.06 million, a P/E ratio of -0.43 and a beta of 0.66. Aterian has a 12 month low of $0.52 and a 12 month high of $1.87.

Aterian (NASDAQ:ATER) last posted its quarterly earnings data on Friday, May 15th. The company reported ($0.39) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.69) by $0.30. Aterian had a negative net margin of 39.56% and a negative return on equity of 82.05%. The business had revenue of $0.02 million during the quarter, compared to analysts’ expectations of $15.82 million.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings upgraded shares of Aterian from a “sell (e+)” rating to a “sell (d-)” rating in a report on Tuesday, May 19th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock currently has a consensus rating of “Sell”.

Aterian Company Profile

Aterian Inc is a technology-driven consumer products company that leverages artificial intelligence and machine learning to develop, source and market branded household, health and personal care products. Through its proprietary data analytics platform, Aterian identifies emerging trends, forecasts demand and optimizes product selection, pricing and distribution. The company maintains a vertically integrated supply chain, overseeing manufacturing partnerships and logistics to support rapid product development and market entry.

Aterian’s portfolio spans a range of categories including home and kitchen, health and wellness, baby care, beauty tools and electronics accessories.